# Annovis Bio, Inc.: Form 8-K, filed Nov 13, 2025

- Company: [Annovis Bio, Inc.](/companies/anvs.md) (CIK 1477845)
- Form: 8-K
- Filed: 2025-11-13
- Accepted by EDGAR: Nov 12, 2025, 17:49 ET
- Period: 2025-11-12
- Accession: 0001104659-25-110548
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1477845/000110465925110548/anvs-20251112x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1477845/000110465925110548/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1477845/000110465925110548/anvs-20251112x8k.htm

Filed Nov 13, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-110548. Last ingested by Listed: Nov 6, 2026, 17:28 ET. No prices; not investment advice.